| Literature DB >> 7549465 |
A Heguy1, A A Stewart, J D Haley, D E Smith, J G Foulkes.
Abstract
Over the last 7 years we have carried out a major research effort focused on gene transcription as a novel approach to drug discovery. The goal is to identify small molecular weight compounds that modulate the expression of a target gene in a specific manner, thereby either increasing or decreasing the concentration of the corresponding protein product. Transcriptional modulation not only provides a potential means to replace recombinant proteins as drugs, but also provides a novel approach to manipulate key gene targets in many therapeutic areas. This article describes some of the features and advantages of transcription-based pharmaceuticals and illustrates how this approach can be applied to drug discovery with a program we are pursuing to identify new treatments for sickle cell disease and beta-thalassemia.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7549465 PMCID: PMC6134365
Source DB: PubMed Journal: Gene Expr ISSN: 1052-2166